Skip to main content
GUD 11.5600 CAD +2.30%
GUD · Knight Therapeutics Inc.
11.5600 CAD +0.2600 (+2.30%) At close · Nov 5 Intraday price with Plus
Market Cap
1.14B CAD
Shares
98.23M
All webcasts

Earnings call · FY2025 Q4

Knight Therapeutics Inc. (GUD) Q4 2025 Earnings Call

Concluded Mar 19, 2026
Mar 19, 2026
Period
FY2025 Q4
Runtime
—
Sources
0 artifacts

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. Event details are collected in one workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document